The Central Drugs Standard Control Organization (CDSCO) has issued corrigendum to its Expression of Interest for development of a Digital Drugs Regulatory System (DDRS). This corrigendum was issued om 10th November, 2023.
It may be recalled that the CDSCO had contemplated the creation of the DDRS as a unified digital ecosystem that will replace existing portals. To bring this idea to fruition it had invited proposals to set up a DDRS on 2nd November, 2023. As per the original invitation, interested Software Service Providers (SSPs) that meet the pre-qualification criteria could submit their Expression of Interest, along with all necessary documents, by 30th November, 2023.
The CDSCO has now extended this deadline for submission of EoIs to 16:00 hours on Wednesday, 7th December, 2023. EoIs must be submitted by email to email@example.com.
The aim of this project is to develop the DDRS as a unified digital ecosystem that will replace existing portals.
Additionally, the corrigendum specifies the following important dates:
- Last date for Submission of Queries (by email only): 22nd November 2023
- Pre-Bid Conference (In hybrid mode) Date and Time: 29th November 2023 at 2:00 P.M.
- Meeting link: https://cdscofda.webex.com/cdscofda/j.php?MTID=m8f94101f113eb8acfee63387705895d3
- Address: Central Drugs Standard Control Organization, FDA Bhawan, Kotla Road, New Delhi-110002
This extension of deadlines for submission of EoIs for the development of DDRs provides an opportunity for increased participation of SSPs in the CDSCO’s endeavour. The development of DDRS represents a step towards enhancing regulatory systems in India, ensuring the availability of quality medicines for the country and the world.